(Q69365593)

English

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer

scientific article published on 01 November 1974

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

title

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

main subject

phase II clinical trial

1 reference

1 reference

D L Ahmann

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

H F Bisel

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

R G Hahn

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

publication date

1 November 1974

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

published in

Cancer chemotherapy reports

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

volume

58

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

issue

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

page(s)

861-865

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

retrieved

30 September 2019

Identifiers

PubMed publication ID

4615785

1 reference

stated in

Europe PubMed Central

PubMed publication ID

4615785

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4615785%20AND%20SRC:MED&resulttype=core&format=json

(Q69365593)

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)